Published: Dec-2022|  Format: PDF | MBI Research |  Number of pages: 140 | Code: MBI-3930736

CRISPR Technology Market Size, Share, Growth & Demand Analysis Report By Product Type (CRISPR Kits, Enzymes and Services) By Application (Industrial Applications, Biomedical Applications, Agricultural Applications, Biological Research) By End-User (Contract Research Organizations, Pharmaceutical and Biopharmaceutical Companies, Biotechnology Companies, Academic and Research Institutes) Forecast Period 2022-2030

Select a Format




 Buy Now

Market Introduction:

The Global CRISPR Technology Market size was valued at USD 2.2 billion in 2021 and is projected to reach a value of USD 8.2 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 19.6% over the forecast period (2022-2030).

The use of this technology in various medical and other non-traditional applications continues to grow. Competition over patents for this gene-editing technology is expected to intensify, with a growing number of academic institutions and biotech companies working towards developing new commercial applications of this technology.

CRISPR is the fastest, easiest, and cheapest of the gene editing tools responsible for this new wave of science. CRISPR is actually a natural process that acts as a bacterial immune system over a long period of time. Originally found to protect single-celled bacteria and archaea from invading viruses, naturally occurring CRISPR uses two main components. The first repeats are short snippets of DNA sequences called "clustered regularly short palindromic repeats" or simply, CRISPRs. Others are Cas, or "CRISPR-associated" proteins that cut DNA like molecular scissors.

CRISPR Technology Market Driving Factors:

CRISPR technology is broadly used in scientific research and medicine because it allows for the treatment and prevention of many diseases. CRISPR is also being explored for fingerprinting cells, turning genes on or off without changing their sequence, and creating gene drives.

Growing advances in molecular biology technologies, increasing prevalence of rare genetic disorders, increasing awareness of the benefits of CRISPR, and growth in research and development studies in genomics and proteomics are some of the major factors that are projected to drive market revenue growth over the forecast period.

CRISPR Technology Market Restraints:

The high frequency of off-target effects during CRISPR gene editing, the potential to cause genetic mutations, and rising ethical concerns regarding gene editing with CRISPR technology are some of the major factors that are expected to hinder the revenue growth of the market during the forecast period. CRISPR technology is also time-consuming and inefficient in some editing cases, and this may further limit its use in molecular biology applications and may prevent market growth to some extent.

CRISPR Technology Market Key Players:

The major players operating in the market are continuously adopting various growth strategies to stay in the market. Product launches, mergers, innovations, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these major players to grow in the competitive market. Major market players are also continuously focusing on R&D to supply industries with the most efficient and cost-effective solutions.

  • AstraZeneca plc.
  • eGenesis
  • F. Hoffmann-La Roche Ltd.
  • Cellectis, CRISPR Therapeutics
  • Addgene
  • Caribou Biosciences, Inc.
  • Editas Medicine, Inc.
  • Horizon Discovery Group plc
  • Danaher Corporation
  • Intellia Therapeutics, Inc.
  • GenScript
  • Lonza
  • Intellia Therapeutics, Inc.
  • Takara Bio Inc.
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Inscripta, Inc.
  • Cibus
  • Synthego
  • Mammoth Biosciences
  • Beam Therapeutics
  • PLANTeDIT
  • OriGene Technologies, Inc.
  • Vertex Pharmaceuticals Incorporated
  • Hera BioLabs
  • Recombinetics, Inc.

CRISPR Technology Market Segmentation:

The global CRISPR technology market is segmented by product type, by applicationend-user, and region.

By Product Type

On the basis of product, the market is segmented into CRISPR Kits, Enzymes, and Services.

The service segment is expected to dominate the market in the forecast period. The cell line engineering services segment is expected to grow at the highest rate.

By Application

On the basis of application, the market is segmented into Industrial Applications, Biomedical Applications, Agricultural Applications, and Biological Research.

Major biomedical applications of CRISPR include gene therapy, drug discovery, and diagnostics. Clinical trials of various gene therapies are currently underway worldwide. Due to these factors, the adoption of CRISPR technology in this segment is expected.

By End-User

On the basis of end-use, the market is segmented into, Contract Research Organizations, Pharmaceutical and Biopharmaceutical Companies, Biotechnology Companies Academic and Research Institutes

The pharmaceutical and Biopharmaceutical Companies segment is expected to dominate the market in the forecast period. Owing to the versatile and potential clinical applications of CRISPR-Cas9, which has ideally encouraged pharmaceutical start-ups to create new products with the aid of CRISPR-mediated gene-editing techniques.

CRISPR Technology Market Regional Analysis:

The global CRISPR technology market is categorized into regions such as Latin America, North America, Europe, Asia-pacific, the Middle East, and Africa.

North America holds the largest market share for CRISPR technology, followed by Europe and Asia Pacific. North America will continue to dominate the global CRISPR technology market over the forecast period due to factors such as increasing research in CRISPR technology and the adoption of CRISPR technology. However, with the growth in this market concentrated in China, India, and Japan, the Asia Pacific region is expected to witness the highest CAGR. Factors such as government support are driving the growth of the CRISPR technology market in this region.

Report Coverage: 

Market Segmentation:

By Product Type

  • CRISPR Kits
  • Enzymes
  • Services
  • Other

By Application

  • Industrial Applications
  • Biomedical Applications
  • Agricultural Applications
  • Biological Research Powder

By End-User

  • Contract Research Organizations
  • Pharmaceutical and Biopharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Institutes

By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Inquiry before buying

Request Sample

Request for Discount

Latest News

Nitric Acid Market Size, Share, Trend Analysis 2022 to 2030

04-Feb-2023 | Chemicals & Materials

Our new latest report titled, Global Nitric Acid Market, comes up with a comprehensive analysis of the industry, including emerging trends and current development of the market. Nitric acid is a colorless liquid that is widely used in a variety ...

Global Robotics Surgical Simulation Systems Market to Grow at a (CAGR) of 16.8% during the Forecast Period 2022-2030

28-Dec-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the Global Robotics Surgical Simulation Systems Market is projected to reach USD 1.71 billion by 2030. Growth in this market is primarily driven by robotic-assisted surgery, technologi ...

Global CRISPR Technology Market to Grow at a (CAGR) of 19.6% during the Forecast Period 2022-2030

27-Dec-2022 | Biotechnology

As specified in our exclusive report, the global CRISPR Technology Market is projected to reach USD 8.2 billion by 2030. The global CRISPR technology market is driven by the increasing focus of market players in CRISPR-CAS9 technology; availability of g ...

Global Gallium Nitride Semiconductor Devices Market to Grow at a (CAGR) of 4.9% during the Forecast Period 2022-2030

26-Dec-2022 | Semiconductor

As specified in our exclusive report, the Global Gallium Nitride Semiconductor Devices Market is projected to reach USD 26.1 billion by 2030. The advantages, such as faster device speed, higher energy efficiency, and lower cost offer ...

Global Lactose Free Dairy Products Market to Grow at a (CAGR) of 7.6% during the Forecast Period 2022-2030

24-Dec-2022 | Food & Beverage

As specified in our exclusive report, the global Lactose Free Dairy Products Market is projected to reach USD 23.8 billion by 2030. The percentage of people with lactose intolerance varies greatly from country to country and continent to continent, ...

More News...